Search - tctmd.com

Displaying 301 - 320 of 465

Sort: Relevancy | Date

Presentation TCT 2015

Recors Trial Program

Presenter: Farrell O. Mendelsohn, William B. White, Laura Mauri

October 11, 2015

Presentation TCT 2015

Update on St. Judes Trial

Presenter: Farrell O. Mendelsohn, William B. White, William A. Gray

October 11, 2015

Presentation TCT 2015

Update on Boston Scientifics REINFORCE

Presenter: Farrell O. Mendelsohn, William B. White, Michael A. Weber

October 11, 2015

Presentation TCT 2015

Update on Medtronics Spyral Global

Presenter: Farrell O. Mendelsohn, William B. White, Michael Böhm

October 11, 2015

Presentation TCT 2015

Considerations and Recommendations for Future Clinical Trials in Device-Based Hypertension Treatments

Presenter: Farrell O. Mendelsohn, William B. White

October 11, 2015

Presentation TCT 2015

Putting It All Together: Procedural Recommendations in 2015

Presenter: Juan F. Granada, Michael Joner, Krishna J. Rocha-Singh

October 11, 2015

Presentation TCT 2015

Influence of Arterial Microanatomy on Response to Renal Artery Catheter Energy Denervation

Presenter: Juan F. Granada, Michael Joner, Elazer R. Edelman

October 11, 2015

Presentation TCT 2015

Time to Revise Treatment Recommendations: Go Distal and Into the Branches

Presenter: Juan F. Granada, Michael Joner, Justin E. Davies

October 11, 2015

Presentation TCT 2015

Lesion Characteristics From the Different Devices: Do They Differ?

Presenter: Juan F. Granada, Michael Joner

October 11, 2015

Presentation TCT 2015

Procedural Parameters for Successful Renal Denervation: Anything on the Horizon?

Presenter: Juan F. Granada, Michael Joner, Michael Böhm

October 11, 2015

Presentation TCT 2015

Nerve Distribution Along the Renal Arteries: From the Branches to the Ostium

Presenter: Juan F. Granada, Michael Joner

October 11, 2015

Presentation TCT 2015

Unresolved Issues and the Path Moving Forward

Presenter: Ajay J. Kirtane, Felix Mahfoud

October 11, 2015

Presentation TCT 2015

Myths as to Why SYMPLICITY HTN-3 Failed

Presenter: Ajay J. Kirtane, Felix Mahfoud, Darrel P. Francis

October 11, 2015

Presentation TCT 2015

Device-Based Therapies for Hypertension Treatment: Procedural Aspects

Presenter: Ajay J. Kirtane, Felix Mahfoud, Farrell O. Mendelsohn

October 11, 2015

Presentation TCT 2015

Uncontrolled Hypertension: Prevalence, Prognosis, and Treatment

Presenter: Ajay J. Kirtane, Felix Mahfoud, Michael A. Weber

October 11, 2015

Presentation CCVVC 2015

New Concepts in Endovascular Treatment: Present And Future Status Of Renal Denervation After The Negative SIMPLICITY Trial

Presenter: Mark Wholey

June 17, 2015

Presentation ISET 2015

Is There Hope for Renal Denervation?

Presenter: Ron Waksman

February 01, 2015

Presentation ISET 2015

Current Challenge and Directions in Renal Denervation

Presenter: Marty B. Leon

February 01, 2015

Presentation

Randomized Comparison of Renal Denervation vs Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension

Presenter: J?n Rosa

December 04, 2014

Presentation TCT 2014

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

Presenter: Michael Joner, Horst Sievert, Steven L. Almany, John A. Ormiston

September 16, 2014

Advertisement

Recors Trial Program

Update on St. Judes Trial

Update on Boston Scientifics REINFORCE

Update on Medtronics Spyral Global

Considerations and Recommendations for Future Clinical Trials in Device-Based Hypertension Treatments

Putting It All Together: Procedural Recommendations in 2015

Influence of Arterial Microanatomy on Response to Renal Artery Catheter Energy Denervation

Time to Revise Treatment Recommendations: Go Distal and Into the Branches

Lesion Characteristics From the Different Devices: Do They Differ?

Procedural Parameters for Successful Renal Denervation: Anything on the Horizon?

Nerve Distribution Along the Renal Arteries: From the Branches to the Ostium

Unresolved Issues and the Path Moving Forward

Myths as to Why SYMPLICITY HTN-3 Failed

Device-Based Therapies for Hypertension Treatment: Procedural Aspects

Uncontrolled Hypertension: Prevalence, Prognosis, and Treatment

New Concepts in Endovascular Treatment: Present And Future Status Of Renal Denervation After The Negative SIMPLICITY Trial

Is There Hope for Renal Denervation?

Current Challenge and Directions in Renal Denervation

Randomized Comparison of Renal Denervation vs Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content